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In bacteria, the majority of exported proteins are transported
by the general Sec pathway from their site of synthesis in the
cytoplasm across the cytoplasmic membrane. The essential
SecA ATPase powers this Sec-mediated export. Mycobacteria
possess two nonredundant SecA homologs: SecA1 and SecA2.
In pathogenic Mycobacterium tuberculosis and the nonpatho-
genic model mycobacteriumMycobacterium smegmatis, SecA1
is essential for protein export and is the “housekeeping” SecA,
whereas SecA2 is an accessory SecA that exports a specific sub-
set of proteins. InM. tuberculosis the accessory SecA2 pathway
plays a role in virulence. In this study, we uncovered basic prop-
erties of the mycobacterial SecA2 protein and its pathway for
exporting select proteins. By constructing secA2mutant alleles
that encode proteins defective in ATP binding, we showed that
ATP binding is required for SecA2 function. SecA2mutant pro-
teins unable to bind ATP were nonfunctional and dominant
negative. By evaluating the subcellular distribution of each
SecA, SecA1 was shown to be equally divided between cytosolic
and cell envelope fractions, whereas SecA2 was predominantly
localized to the cytosol. Finally, we showed that the canonical
SecA1 has a role in the process of SecA2-dependent export.
The accessory SecA2 export system is important to the phys-
iology and virulence of mycobacteria. These studies help
establish the mechanism of this new type of specialized pro-
tein export pathway.
In bacteria, proteins exported beyond the cytosol to the bac-
terial cell envelope or secreted into the extracellular environ-
ment are important for establishing cell wall structure, acquir-
ing nutrients, and responding to changes in the environment.
Surface and secreted proteins of bacterial pathogens are also
ideally positioned to interact with host cells; consequently,
these proteins and the systems that export them are important
for virulence (1). Studies of bacterial protein export systems
could yield new targets for antimicrobial therapies.
Many bacterial pathogens use specialized systems to export
virulence factors (2, 3). In mycobacteria and a small subset of
Gram-positive bacteria, there are accessory Sec systems that
can be considered specialized protein export systems (4–11).
The accessory Sec pathway is linked to virulence in several cases
includingMycobacterium tuberculosis, Listeriamonocytogenes,
and Streptococcus gordonii (5, 12–14). The common constitu-
ent of the accessory Sec pathways studied so far is an accessory
SecAhomolog called SecA2. SecA2 is homologous to the essen-
tial SecA (SecA1) that is part of the general Sec pathway present
in all bacteria (15).
Studies of the general Sec pathway show that the canonical
SecA plays a central role in the process of guiding proteins that
are synthesized as precursors withN-terminal signal sequences
across the cytoplasmic membrane through a channel com-
prised of the SecYEGproteins (16, 17). Energy for protein trans-
location is provided by the ATPase activity of SecA. With
repeated cycles of ATP binding and hydrolysis, SecA undergoes
conformational changes that allow it to ratchet precursor pro-
teins through the SecYEG translocase (18). ATPase activity is
essential to SecA function (19). Mutants defective in SecAATP
binding/hydrolysis are unable to complement temperature-
sensitive secAmutants (19–21).
In mycobacteria, there are two SecA proteins called SecA1
and SecA2. SecA1 is essential and is the housekeeping SecA of
the mycobacterial general Sec pathway (4, 22, 23). In contrast,
SecA2 is not essential in mycobacteria. Mutants with the secA2
gene deleted have been constructed in pathogenicM. tubercu-
losis and in nonpathogenic Mycobacterium smegmatis (4, 5).
The secA2 mutant of M. tuberculosis is attenuated in mouse
and macrophage models of infection, which demonstrates the
importance of SecA2 to M. tuberculosis virulence (5, 13). The
secA2 mutant of M. smegmatis exhibits a growth defect on
rich agar and hypersensitivity to sodium azide (4). Two-dimen-
sional gel analysis comparing exported proteins from wild type
versus secA2mutantM. tuberculosis andM. smegmatis iden-
tifies a small number of proteins that depend on SecA2 for
export (5, 24). InM. tuberculosis, the SodA protein is one of the
few proteins identified as requiring SecA2 for its secretion (5).
In M. smegmatis, two lipoproteins with N-terminal signal
sequences (Msmeg1712 and Msmeg1704) require SecA2 for
their export to the cell wall (24).
Both SecA1 and SecA2 have ATP-binding Walker Box
motifs, and the purified M. tuberculosis proteins bind and
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hydrolyze ATP in vitro (25). Previously, we showed that M.
tuberculosis SecA2 with a mutated Walker Box is defective in
ATP binding in vitro (25). To study the biological significance
of ATPase activity in vivo, we tested the effect of amino acid
substitutions in theWalker Box of SecA2when expressed inM.
smegmatis and M. tuberculosis. The bulk of our studies here
focused on a particular Walker Box mutant of M. smegmatis
SecA2, SecA2K129R.We showed SecA2K129R to be unable to
fulfill its role in exporting SecA2-dependent proteins. We fur-
ther discovered that in several assays SecA2 K129R not only
failed to complement secA2mutant phenotypes but behaved
as a dominant negative. In the process of characterizing the
dominant negative SecA2 protein, we showed that wild type
SecA2 protein is predominantly localized to the cytosol, which
is notably different from the subcellular distribution of SecA1
and SecA2 K129R.
The accessory SecA2 system of mycobacteria is unlike the
accessory SecA2/Y2 systems of S. gordonii and Streptococcus
parasanguinis in that it lacks an accessory SecY2 protein for
export (6, 8, 26, 27). Without an obvious translocase, we con-
sidered the possibility that SecA2 uses the canonical Sec
machinery (SecA1/SecYEG) to promote export of its select sub-
set of proteins. Using M. smegmatis strains engineered to
deplete SecA1, we showed that export of the SecA2-dependent
substrate Msmeg1712 was severely impaired in the absence of
SecA1. This result indicates SecA1 is required for SecA2-de-
pendent export. It represents the first piece of evidence indicat-
ing a role for a canonical SecA1 in exporting substrates of an
accessory SecA2 pathway.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Plasmids, and Culture Conditions—M.
smegmatis was grown in Middlebrook 7H9 or on 7H10 (BD
Biosciences) supplemented with 0.2% (w/v) glucose, 0.5% (v/v)
glycerol, and 0.1% (v/v) Tween 80 (Fisher); or Mueller Hinton
(BD Biosciences) supplemented with 0.1% (v/v) Tween 80. M.
tuberculosis was grown in 7H9 or on 7H10 supplemented with
0.5% (v/v) glycerol and 1ADS (0.5% (w/v) bovine serum albu-
min, 0.2% (w/v) dextrose, and 0.85% (w/v) NaCl). For cultures
of mycobacteria, the antibiotics kanamycin (Acros Chemicals)
andhygromycin (RocheApplied Science)were added as needed
at 20 or 50 g/ml, respectively. Luria Bertani was used to grow
Escherichia coli cultures. When needed, kanamycin or hygro-
mycin was added at 40 or 150 g/ml, respectively. All of the
plasmids used in this study are listed in supplemental Table S1,
and cloned sequences were verified by DNA sequencing (Uni-
versity of North Carolina at Chapel Hill DNA sequencing facil-
ity and Eton Biosciences). Throughout this work, mc2155 and
H37Rv were used as the wild type strains ofM. smegmatis and
M. tuberculosis, respectively. NR116 (described below) was
used as the secA2 mutant of M. smegmatis, and mc23112 (5)
was used as the secA2mutant ofM. tuberculosis.
Construction of secA2 Mutant M. smegmatis NR116—The
previously published M. smegmatis secA2 mutant (mc22522)
is an in-frame, unmarked deletion of approximately one-third
of the secA2 gene (4). For this study a complete in-frame
unmarked deletion ofM. smegmatis secA2 (NR116) was used in
which only three codons of the secA2 open reading frame
remain. All of the phenotypes observed for mc22522 were also
observed for NR116. NR116 was constructed in the following
manner: (i) secA2 suicide plasmid pNR6. Sequences immediately
upstream of secA2 were PCR-amplified from M. smegmatis
genomic DNA using primers 5-GTCGACCGACAGGTTCC-
AGCCGTAGAA-3/5-GTCGACCACGGCGTCAGTTGTG-
CCTCG-3 and sequences immediately downstream of secA2
were PCR-amplified using the primers 5-GTCGACTAGGC-
CCCAGCCATTAGGTTC-3/5-TGATATCGAGCACCTC-
CCAGCCCCATTC-3. The upstreamPCRproductwas cloned
into the vector pCC1 using the Copy Control PCR cloning kit
(Epicenter) to generate pNR3. The downstream PCR product
was cloned into the vector pCR2.1 (Invitrogen) to generate
pNR4. A 1087-bp SalI fragment of pNR3 was ligated into SalI-
cut pNR4. The resulting plasmid, pNR5, contained a 2385-bp
deletion of secA2, leaving only three codons. A 1737-bp MscI-
EcoRV fragment containing the secA2 deletion was cut from
pNR5 and cloned into the EcoRV site of the counterselectable
suicide plasmid pYUB657, yielding vector pNR6. (ii) Two step
allelic exchange. The secA2 mutant strain NR116 was con-
structed by two-step allelic exchange as described previously (4,
28, 29). Wild type M. smegmatis strain mc2155 was electropo-
rated with pNR6, and hygromycin-resistant transformants
were selected. Transformants were screened by Southern blot
to identify a single-cross-over integration of pNR6 at the chro-
mosomal secA2 locus yielding strain SCO5. To resolve the sin-
gle cross-over strain, a saturated culture of SCO5 was diluted
1:100 into 7H9 without hygromycin and grown overnight at
37 °C. This culture was then plated onto 7H10 supplemented
with 4.5% (w/v) sucrose to select against the sacB marker
encoded on the backbone of the suicide vector. Sucrose-resis-
tant clones were screened for hygromycin sensitivity. Sucrose-
resistant, hygromycin-sensitive cloneswere screened by South-
ern blot analysis (data not shown) for evidence of a second
recombination event leading to chromosomal deletion of secA2
(30). Briefly, genomic DNA was isolated from M. smegmatis
strains and digested with BamHI. The probe used was the
1093-bp PCR product containing the sequence immediately
upstream of secA2, used to generate pNR3. The resulting in-
frame, unmarked secA2 deletion mutant derived from SCO5
was named NR116.
Construction of secA2 Walker Box Mutant Plasmids pNR7
and pNR25—The QuikChange site-directed mutagenesis kit
(Stratagene) was used tomutate the DNA encoding theWalker
Boxes of secA2 using plasmid templates pMB162 forM. tuber-
culosis secA2 and pYA810 forM. smegmatis secA2 (4, 24). Both
pMB162 and pYA810 vectors integrate at the chromosomal
attB site of mycobacteria, and both plasmids express their
respective secA2 genes from the hsp60 promoter. TheWalkerA
motif of M. tuberculosis SecA2 was mutated in plasmid
pMB162 using the following primers: 5-CGGTGAGGGCA-
GAACCCTTGCC-3 and 5-CGGCAAGGGTTCTGCCCT-
CACC-3. The resulting mutant plasmid contained secA2
K115R andwas namedpNR7.To create the comparableWalker
A mutation in M. smegmatis secA2, which is K129R, primers
5-CGGGTGAGGGCAGGACGCTGGC-3 and 5-GCCAG-
CGTCCTGCCCTCACCCG-3 were used with pYA810 as the
template to generate plasmid pNR25.
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Construction of Inducible secA2 K129R Plasmid pNR54 (Tet
ON)—M. smegmatis secA2was PCR-amplified with primers 5-
AGGATCCATCCGGAGGAATCACTT-3 and 5-AGGATC-
CCTAGTGGTGGTGGTGGTGGTGGCGGAACACACCC-
GGCAGG-3 and cloned into pCC1 to yield pNR52. Next, a
2.4-kb BamHI fragment was cloned from pNR52 into similarly
cut pMP715 (kind gift from Dr. Martin Pavelka, University of
Rochester). The resulting plasmid pNR53 has the secA2 gene
cloned adjacent to the TetO operators. The vector pMP715 is
an episomal plasmid that carries the Tet operator sequence
from pSE100 (23), encodes the TetR repressor protein from
pMC1s (31), and carries a kanamycin resistance gene. As with
the precursor plasmids pSE100 and pMC1s, plasmid pMP715
can be used to achieve tetracycline regulation of gene expres-
sion (23) using anhydrotetracycline (Atc).6 To mutate Walker
Box residue K129, pNR53 was subjected to site-directed
mutagenesis as described above. The resulting plasmid pNR54
carries secA2 K129R under control of the regulatable promoter.
Induction of SecA2 K129R in M. smegmatis transformed with
pNR54was achieved by treating cultures with 100 or 200 ng/ml
Atc for 21 h at 37 °C.
Construction of Conditional secA1 Strains—As described
previously, the SecA1 depletion strain MSE10 was used (23).
For this study,we additionally introduced the conditional secA1
allele into the secA2 mutant background. NR116 was trans-
formed with the suicide plasmid pKIsecA1 (kind gift from Dr.
Sabine Ehrt, Weill Cornell Medical College), and hygromycin-
resistant transformants were selected on 7H10 plates. Trans-
formants were screened by Southern blot (data not shown) to
detect integration of pKIsecA1 at the native secA1 locus in the
chromosome. Genomic DNA was isolated from M. smegmatis
strains and digested with BamHI and EcoRI. The probe used
was a 410-bp SphI-MscI fragment from pKIsecA1. The result-
ing strain was named JM693. To achieve regulation of SecA1 in
strains MSE10 and JM693, each strain was transformed with
pNR55 (described below) and treated with or without 600
ng/ml Atc.
Construction of Msmeg1712-HA revTetR Plasmid pNR55
(Tet OFF)—Tomonitor the effect of SecA1 depletion on export
of Msmeg1712-HA, we constructed a plasmid that constitu-
tively expresses both Msmeg1712-HA and the reverse TetR
repressor (revTetR). To construct pNR55, a 2392-bpNheI frag-
ment containing revTetR was excised from pTEK-4S0X (23)
and ligated into the NheI site of pHSG85 (24). pHSG85 was
constructed by cloning a NotI-HindIII fragment containing
themsmeg1712 gene and the promoter region from pHSG83
(24) into similarly cut pMV261.kan. Vector pNR55 produces
Msmeg1712 tagged at the C terminus with the hemaggluti-
nin (HA) epitope.
Macrophage Infections—Bone marrow macrophages were
elicited from the femurs of C57BL/6 mice, as described previ-
ously (13, 25). 2.5  105 macrophages/well were seeded into
8-well chamber slides. M. tuberculosis strains were grown to
mid-exponential phase, washedwith phosphate-buffered saline
containing 0.05% Tween 80, diluted in tissue culture medium
(Dulbecco’s modified Eagle’s medium supplemented with 10%
heat-inactivated fetal calf serum, 2mM glutamine, and 1 non-
essential amino acids; Invitrogen), and added to the macro-
phages at a multiplicity of infection of 1.0. Macrophages were
infected for 4 h at 37 °C in 5% CO2. On days 0, 3, and 5 post-
infection, the contents of triplicatewells for each infectionwere
lysed with 1 phosphate-buffered saline 0.05% Tween 80. The
lysates were diluted and plated ontoMiddlebrook 7H10 agar to
enumerate intracellular bacteria during infection.
Azide Sensitivity Assay—200 l of saturated M. smegmatis
culture was mixed with 3.5 ml of molten 7H9 top agar and then
poured onto a 7H10 bottom agar plate. Sterile 6-mm filter discs
were placed onto the surface of the cooled top agar. 10l of 0.15M
sodiumazidewas then added to the disc. The plateswere inverted
and incubated for 2 days at 37 °C, and the resulting zones of inhi-
bition were measured. Each strain was tested in triplicate.
Epitope-tagged Expression Vectors for Msmeg1704 and
Msmeg1712—To monitor the export of Msmeg1704 and
Msmeg1712, both proteins were tagged with the HA epitope at
the C terminus and expressed from hygromycin-resistant epi-
somal plasmids pNR35 (Msmeg 1712-HA) and pNR36
(Msmeg1704-HA) (24). These vectors were constructed by
replacing the kanamycin marker of pHSG51 and pHSG58 with
the 1.5-kb SmaI-EcoRV hygromycin resistance fragment from
pYUB412.7
Subcellular Fractionation—To determine the subcellular
localization of proteins in M. smegmatis, we fractionated bac-
terial whole cell lysates as described previously (24).Whole cell
lysates were generated by five passages through a French pres-
sure cell. For Msmeg1704-HA and Msmeg1712-HA localiza-
tion, the lysates were separated by differential ultracentrifuga-
tion into cell wall (27,000  g pellet), membrane (100,000  g
pellet), and soluble (100,000  g supernatant) fractions. For
SecA1 and SecA2 localization experiments, the lysates were
separated into cell envelope (100,000  g pellet) and soluble
(100,000 g supernatant) fractions. In all cases, protein derived
from the same amount of starting cells for each fraction was
analyzed by SDS-PAGE and immunoblots.
Immunoblot Conditions—The anti-SecA2 (23), anti-GroEL
(HAT5/IT-64, from the World Health Organization anti-
body collection), anti-MspA (gift from Dr. Michael Nieder-
weis (32)), and anti-HA (Covance) antibodies were used at
1:20,000 dilutions. The anti-SecA1 antibody (23) was used at
a 1:50,000 dilution. In some experiments, secondary anti-
bodies conjugated to horseradish peroxidase (Bio-Rad) were
used along with Western Lightening Chemiluminescent
detection reagent (PerkinElmer Life Sciences). For quantita-
tive westerns, secondary antibodies conjugated to alkaline
phosphatase were used and detected using the ECF reagent
(GE Healthcare). Fluorescence was quantified using a phos-
phorimager and ImageQuant 5.2 (Molecular Dynamics).
RESULTS
M. smegmatis Is a Valid Model for Studying the M. tubercu-
losis SecA2 System—Because of the challenges that accompany
working withM. tuberculosis (slow growth and Biosafety Level
6 The abbreviations used are: Atc, anhydrotetracycline; WT, wild type; HA,
hemagglutinin; SOL, soluble. 7 S. Bardarov and W. R. Jacobs, Jr., unpublished observation.
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3 practices), the fast growing nonpathogen M. smegmatis is
often used as a model mycobacterium (33).M. smegmatis has a
functional SecA2 export system (4, 24). Previously, we showed
that M. tuberculosis SecA2 can function in M. smegmatis as
demonstrated by the ability of M. tuberculosis SecA2 to com-
plement phenotypes of anM. smegmatissecA2mutant (4). To
further demonstrate functional conservation between the M.
tuberculosis and M. smegmatis SecA2 systems, we tested the
ability ofM. smegmatis SecA2 to function inM. tuberculosis.
M. smegmatis secA2 Complements the Macrophage Growth
Defect of a M. tuberculosis secA2 Mutant—M. tuberculosis
strain H37Rv can grow inside macrophages over a period of
several days, whereas the secA2 mutant is defective in
intracellular growth (13). We tested the ability of M. smeg-
matis SecA2 to function in M. tuberculosis by infecting
murine bone marrow-derived macrophages with wild type
M. tuberculosis (H37Rv), the secA2 mutant mc23112, the
secA2 mutant complemented with wild type M. tuberculo-
sis secA2 (secA2/Mtb secA2), or the secA2 mutant ex-
pressing wild typeM. smegmatis secA2 (secA2/Msm secA2)
(Fig. 1). As shown previously (13), H37Rv and the secA2
mutant complemented withM. tuberculosis secA2 grew sim-
ilarly in macrophages over a 5-day period of infection,
whereas the secA2 mutant failed to grow in these macro-
phages. Introduction of M. smegmatis secA2 encoded on
pYA810 in single copy at the chromosomal attB site also
enabled the secA2 mutant to grow in macrophages.
The M. tuberculosis secA2 Mutant Has a Smooth Colony
Phenotype That Is Complemented by M. smegmatis secA2—In
contrast to the dull, rough, irregularly shaped colonies of wild
typeM. tuberculosis, colonies of the secA2mutant are round
and smoothwith a glossy appearance.Notably, this difference is
only detectedwhen the bacteria are grown onmedia containing
Tween 80 detergent. When grown on 7H10 plates without
Tween 80, wild type and secA2 mutant colonies are indistin-
guishable (data not shown). To further test the ability of M.
smegmatis secA2 to complement the M. tuberculosis secA2
mutant, we grew the same M. tuberculosis strains used in the
macrophage experiments on 7H10 plates supplemented with
0.05% Tween 80. After 3 weeks of growth, the plates were pho-
tographed. As shown in Fig. 2A, thesecA2mutant was notice-
ably smoother than wild type H37Rv. Expression of M. tuber-
culosis secA2 or M. smegmatis secA2 in the secA2 mutant
restored the rough colony morphology to the secA2mutant.
With the above assays, we showed thatM. smegmatis SecA2
can substitute forM. tuberculosis SecA2 during growth inmac-
rophages and in standard laboratory conditions. These experi-
ments demonstrate functional conservation betweenM. tuber-
culosis SecA2 andM. smegmatis SecA2, and they argue thatM.
smegmatis is a valid model for studying SecA2 function in pro-
tein export.
ATP Binding Is Required for SecA2 Function—M. tuberculo-
sis SecA2 is able to bind and hydrolyze ATP in vitro (25). A
lysine to arginine substitution (K115R) in theWalker Box ofM.
tuberculosis SecA2 significantly decreases ATP binding in vitro
(25). To assess the biological significance of ATP binding to
SecA2, we tested the ability of SecA2Walker Box mutants to
function in M. smegmatis. Plasmid pNR25, expressing M.
smegmatis secA2 K129R (the equivalent of the K115R muta-
tion inM. tuberculosis secA2) was generated by site-directed
mutagenesis of wild type secA2 carried on pYA810. Wild
type and secA2 mutant M. smegmatis strains were trans-
formed with pNR25 or pYA810, and the transformants were
tested for secA2 mutant phenotypes, starting with the
export of SecA2-dependent proteins.
M. smegmatis secA2 K129R Fails to Support Export of SecA2-
dependent Proteins—Msmeg1704 andMsmeg1712 are lipopro-
teins that depend on SecA2 for export to the cell wall of M.
smegmatis (24). To directly assess whether ATP binding is
required for SecA2 function in promoting protein export, we
tested whether the Walker Box mutant secA2 K129R can sup-
FIGURE 1. Both M. tuberculosis and M. smegmatis secA2 can complement
the macrophage growth defect of a M. tuberculosis secA2 mutant.
Murine bone marrow-derived macrophages were infected at a multiplicity of
infection of 1.0 with the following strains: H37Rv (wild type), mc23112 (secA2
mutant), mc23112 complemented with wild type M. tuberculosis secA2
encoded on pMB162 (secA2/Mtb secA2), and mc23112 complemented with
wild type M. smegmatis secA2 encoded on pYA810 (secA2/Msm secA2). Col-
ony forming units (CFU) were determined by plating macrophage lysates. The
infection was performed with triplicate wells for each strain. The error bars
represent  standard deviation of the mean. The data are representative of
two independent experiments. *, p  0.05.
FIGURE 2. Complementation of a smooth colony phenotype of the M.
tuberculosis secA2 mutant. A, wild type and secA2 mutant M. tuberculosis
strains were transformed with pMV306.kan (empty vector), wild type M.
tuberculosis secA2 encoded on pMB162 (Mtb secA2), or wild type M. smegmatis
secA2 encoded on pYA810 (Msm secA2). B, wild type and secA2 mutant M.
tuberculosis strains were transformed with Walker Box mutant secA2 alleles
from M. tuberculosis encoded on pNR7 (secA2 K115R), or M. smegmatis secA2
K129R encoded on pNR25 (secA2 K129R). All transformants were grown on
7H10 plates containing 0.05% Tween 80 and photographed after 3 weeks of
growth at 37 °C.
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port export of these two SecA2-dependent proteins. To moni-
tor export, each protein was tagged with the HA epitope at the
C terminus. The tagged proteins were expressed in wild type
(WT)M. smegmatis, secA2mutant (), secA2mutant com-
plemented with wild type secA2 (/WT), or thesecA2mutant
expressing the secA2 K129R allele (/KR). Equivalent expres-
sion of SecA2 and SecA2 K129R in the complemented strains
was confirmed by Western blot (data not shown). To assay
export, the cells were lysed, and the whole cell lysate was then
fractionated into cell wall, membrane, and soluble (SOL) frac-
tions by differential ultracentrifugation. Proteins derived from
an equivalent number of starting cells were analyzed for each
fraction by SDS-PAGE and Western blot with anti-HA anti-
bodies (Fig. 3A). As expected, the secA2 mutant failed to
export Msmeg1704-HA and Msmeg1712-HA to the cell wall
fraction (24). Moreover, both proteins accumulated in the sol-
uble fraction of thesecA2mutant (), which is consistent with
an export defect and subsequent retention of unexported pro-
tein in the cytoplasm. As was also demonstrated previously,
expression of wild type secA2 in the secA2 mutant (/WT)
complemented the export defect of Msmeg1704-HA and
Msmeg1712-HA to the cell wall. However, when secA2 K129R
was expressed in a secA2 mutant (/KR), Msmeg1704-HA
and Msmeg1712-HA failed to reach the cell wall and accumu-
lated in the soluble fraction. These results indicated that SecA2
K129R is unable to function in exportingM. smegmatis SecA2-
dependent proteins.
M. smegmatis secA2 K129R Fails to Complement and Exac-
erbates Phenotypes Associated with a M. smegmatis secA2
Mutant—TheM. smegmatis secA2mutant exhibits a growth
defect on rich agar medium, such as Mueller Hinton, when
comparedwith wild type bacteria (4). This growth phenotype is
restricted to platemedia; no growth defect is observedwhen the
secA2mutant is grown in liquid broth (data not shown). The
secA2 mutant also exhibits increased sensitivity to azide, an
inhibitor of ATPases (4). We further tested the functionality of
SecA2 K129R by assessing its ability to complement the rich
agar and azide phenotypes of thesecA2mutant.M. smegmatis
secA2 K129R failed to complement both the rich agar growth
defect (Fig. 3B) and azide hypersensitivity (Fig. 3C) of the
secA2mutant.Moreover, expression of SecA2K129R resulted
in phenotypesmore severe than that of thesecA2 null mutant.
M. smegmatis secA2 K129R Is a Dominant Negative Allele—
When secA2 K129Rwas expressed in wild typeM. smegmatis it
led to the appearance of phenotypes like those exhibited by the
secA2 mutant. Such a merodiploid strain (secA2/secA2
K129R) exhibited a rich agar growth defect and azide sensitivity
phenotype that is comparable with that seen with the secA2
mutant (Fig. 3, B and C). Because this strain carries wild type
secA2 at the chromosomal locus and has secA2 K129R inte-
grated in the chromosomal attB site, this result indicated that
secA2 K129R is dominant negative.
Dominant negative mutations produce a gene product that
interferes with the function of the wild type gene product in
merodiploids to generate a null mutant phenotype (34). Dom-
inant negative mutations usually occur when a mutant protein
can still interact with the same proteins as thewild type protein,
but themutation blocks its function such that only nonproduc-
tive protein complexes form (35, 36).
Dominant negative alleles are typically dosage-dependent
(34, 37, 38). To directly demonstrate a dosage-dependent dom-
inant negative phenotype, we used an inducible promoter sys-
tem to test the effects of high level expression of SecA2 K129R
in a controlled fashion. The inducible system we used is based
on the Tet operator (Tet ON) (23, 31).We cloned secA2 K129R
downstream of two TetO sites on plasmid pMP715, which
additionally carries the repressor protein TetR, to generate
pNR54. TetR binds to the TetO sites and blocks expression of
secA2K129R. However, in the presence of the inducermolecule
Atc, TetRwill dissociate fromTetO sites allowing expression of
secA2 K129R. The level of secA2 K129R expression can be con-
trolled by adjusting the concentration of Atc.
Wild type and secA2 mutant M. smegmatis strains were
electroporated with pNR54, and the resulting transformants
were grown inMueller Hinton broth  Atc induction. Growth
was monitored by measuring optical density. After 21 h of
induction, serial dilutions of each culture were plated onto
Mueller Hinton plates  Atc supplementation. As the concen-
tration of inducer increased in the growth medium, a corre-
sponding increase in SecA2 K129R expression was detected by
SecA2 immunoblots (data not shown). High level expression of
SecA2K129R in bothwild type andsecA2mutant strain back-
grounds led to reduced growth in rich liquid medium as
revealed by growth curves (Fig. 4, A and B). This was the first
timewe have observed any growth defect in liquidmedium that
FIGURE 3. M. smegmatis secA2 K129R fails to complement and exacer-
bates M. smegmatis secA2 mutant phenotypes. A, WT, secA2 mutant
(), secA2 mutant complemented with wild type secA2 (/WT), and secA2
mutant expressing secA2 K129R (/KR) M. smegmatis strains were trans-
formed with vectors expressing HA-tagged Msmeg1704 (pNR36) or
Msmeg1712 (pNR35). Whole cell lysates (WCL) were prepared from each
strain and used to prepare cell wall (CW), membrane (MEM), and SOL fractions.
Protein derived from an equal number of starting cells was analyzed by SDS-
PAGE and immunoblot using anti-HA antibodies. B, M. smegmatis colonies
grown on Mueller Hinton agar for 4 days at 37 °C. Shown from left to right are
wild type M. smegmatis (WT) and secA2 mutant () strains carrying empty
vectors, the secA2 mutant expressing wild type secA2 (/WT), the secA2
mutant expressing secA2 K129R (/KR), and wild type M. smegmatis express-
ing secA2 K129R (WT/KR). Colonies of the /KR strain appeared upon
extended incubation. C, the same strains in B were tested for sensitivity to
0.15 M sodium azide spotted on a filter disc. The size of the zone of clearing
reports on azide sensitivity of each strain.
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is related to SecA2.As expression of SecA2K129R increased, an
increasingly severe rich agar growth defect was also observed in
both wild type and secA2 M. smegmatis (Fig. 4, C and D). In
fact, growth on agar was inhibited with the highest concentra-
tion of Atc tested. As a control, we confirmed that overexpres-
sion of wild type SecA2 from the same Tet ON system did not
cause the same effects (data not shown). These results
showed that the rich agar growth defect associated with
SecA2 K129R is dosage-dependent, and they are consistent
with secA2 K129R being a true dominant negative. They also
showed that high level expression of SecA2 K129R inhibits
growth of M. smegmatis.
Walker Box Mutant secA2 Alleles Are Dominant Negative in
M. tuberculosis—TheWalker Box mutant alleles of secA2were
also tested inM. tuberculosis. Plasmids expressingM. tubercu-
losis SecA2 K115R (pNR7) and M. smegmatis SecA2 K129R
(pNR25) were introduced into wild type andsecA2mutantM.
tuberculosis, and the resulting strains were plated on 7H10 agar
containing Tween 80 (Fig. 2B). In the secA2 mutant, secA2
K115R and secA2 K129R failed to complement the smooth col-
ony phenotype of the secA2 mutant, as expected. When
expressed in wild type M. tuberculosis, M. tuberculosis secA2
K115R andM. smegmatis secA2 K129R changed the rough col-
ony appearance of wild type to a smooth phenotype similar to
that of the secA2 mutant. These results are consistent with
secA2 K115R and secA2 K129R also functioning as dominant
negative alleles in pathogenicM. tuberculosis.
Differences in the Subcellular Localization of SecA1, SecA2,
and SecA2 K129R—In E. coli, the single SecA is evenly distrib-
uted between cell envelope and soluble fractions (39). To estab-
lish the subcellular localization of SecA1, SecA2, and SecA2
K129R, we generated cell envelope (comprised of cell wall and
cell membrane) and soluble (comprised of cytosol) fractions of
M. smegmatis and performedquantitative immunoblot analysis
on these fractions with anti-SecA1 and anti-SecA2 antibodies.
Immunoblots for the cell wall protein MspA (M. smegmatis
porin A), and the soluble cytoplasmic chaperone GroEL were
used to establish the purity of the fractions. These experiments
demonstrated SecA1 to be equally distributed between cell
envelope and soluble fractions (Fig. 5, A and E). This result is
like that reported for E. coli SecA (39) and is consistent with
SecA1 being the “housekeeping” secretion factor of mycobac-
teria. The same subcellular fractionationwas also performed on
the secA2 mutant and showed that absence of SecA2 had no
impact on expression or localization of SecA1 (Fig. 5B).
Subcellular localization of SecA2 revealed a distinguishable
feature of the SecAs. Unlike SecA1, in wild type M. smegmatis
FIGURE 4. SecA2 K129R is dosage-dependent. Wild type and secA2
mutant M. smegmatis strains were transformed with pNR54 encoding induc-
ible secA2 K129R under control of the Tet ON promoter. Strains were grown in
Mueller Hinton broth with different concentrations of Atc (closed circle, 0
ng/ml; open circle, 100 ng/ml; closed triangle, 200 ng/ml). Growth of wild type
(A) and secA2 mutant (B) was monitored by measuring A600 nm. At 21 h post-
inoculation, serial dilutions of the wild type (C) and secA2 mutant (D) from
each culture in the growth curve were plated onto Mueller Hinton plates, all
of which contained 500 ng/ml Atc. Shown are colonies on plates incubated at
37 °C for 3– 4 days. Even after extended incubation, colonies did not appear
from cultures treated with 200 ng/ml Atc during liquid growth.
FIGURE 5. Subcellular localization of SecA1, SecA2, and SecA2 K129R in M. smegmatis. Cultures of WT (A), secA2 mutant (, B), secA2 mutant comple-
mented with secA2 (/WT, C), and secA2 mutant expressing secA2 K129R (/KR, D) were used to prepare whole cell lysate (WCL), SOL, and cell envelope (ENV)
fractions. Protein derived from an equal number of cells was analyzed using anti-SecA1 and anti-SecA2 antibodies. The cell wall porin MspA and the cytoplas-
mic chaperone GroEL are controls for the fractionation. Percent localization to a given fraction for SecA1 (E) and SecA2 (F) was determined by quantitative
immunoblot analysis of the fractions and is reported as the percentage of the total (SOL fraction plus cell envelope). The error bars indicate the standard error
of the mean of three independent replicates for each strain.
SecA2 Export Requires ATP Binding and SecA1
9932 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 284 • NUMBER 15 • APRIL 10, 2009
SecA2 was predominantly localized to the soluble cytosolic
fraction (Fig. 5, A and F). M. smegmatis SecA2 protein ex-
pressed in a complemented strainwas also found to be predom-
inantly cytosolic (Fig. 5C).
When we evaluated the subcellular distribution of SecA2
K129R, we found a striking difference from the cytosolic local-
ization of wild type SecA2. SecA2 K129R was predominantly
associated with the cell envelope fraction (Fig. 5, D and F). The
shift in the localization pattern of SecA2 K129R suggests the
dominant negative protein exerts its effects while trapped in a
complex at the membrane. This is consistent with a model of
SecA2 normally interacting in a transient manner with a mem-
brane-embedded channel to deliver proteins for export and/or
to energize the translocation process.
SecA1Depletion Impacts Export of the SecA2-dependent Sub-
strate Msmeg1712—If SecA2 uses the canonical SecA1/Sec-
YEG machinery to export its select subset of proteins, then the
export of SecA2-dependent proteins should also depend on
these essential secretion factors. To study any contribution of
essential Sec proteins to SecA2-dependent export, conditional
sec strains are required. Recently, an M. smegmatis strain
MSE10 was constructed where the chromosomal copy of secA1
can be conditionally regulated with the tetracycline operator/
repressor system (23). Using the repressible (Tet OFF) system,
the revTetR repressor binds TetO in the presence of Atc to
block expression of SecA1 (31).
To test the contribution of SecA1 in SecA2-dependent
export, conditional SecA1 strains were engineered to addi-
tionally express Msmeg1712-HA. This was achieved with
plasmid pNR55 that constitutively expresses both the revTetR
repressor protein and Msmeg1712-HA. This plasmid was intro-
duced intoMSE10, which contains secA1 cloned behind theTetO
operator in the wild typeM. smegmatis strain mc2155 (23). Plas-
mid pNR55 was also introduced into strain JM693, which carries
the same secA1 conditional allele in asecA2mutant background
(see “ExperimentalProcedures”).Theresultingstrainsweregrown
inMueller Hinton with or without Atc for 21 h to deplete SecA1.
TheAtc treatment didnot impair growthof the cultures. The cells
were harvestedby centrifugation, lysed, and fractionatedbydiffer-
ential ultracentrifugation. Subcellular fractions were then ana-
lyzed by SDS-PAGE and immunoblot to assess the export of
Msmeg1712-HA to the cell wall.
The addition of Atc resulted in greater than 95% reduction of
SecA1, as determined by quantitative Western blots. Impor-
tantly, under the conditions used depletion of SecA1 did not
have any global effect on protein expression as shownby immu-
noblot analysis of control proteins GroEL or MspA. Thus, our
Atc treatment conditions specifically influenced SecA1. As
expected,MspA,which is a previously reported SecA1-depend-
ent exported protein, was not exported to the cell wall fraction
ofM. smegmatis when SecA1 was depleted (23).
In the presence of SecA1 (i.e. Atc), Msmeg1712-HA was
exported to the cell wall and membrane fractions in wild type
M. smegmatis (MSE10), as expected. Strikingly, when SecA1
was depleted fromMSE10 by Atc addition,Msmeg1712-HAno
longer efficiently localized to the cell wall fraction (Fig. 6,A and
B). Quantification of our blots showed a 90% reduction in
Msmeg1712-HA in the cell wall fraction of the SecA1-depleted
strain (Atc) compared with the untreated strain (Atc). Fur-
thermore, Msmeg1712-HA specifically accumulated in the sol-
uble fraction when SecA1 was depleted (Atc), which is con-
sistent with an export defect for Msmeg1712-HA.
A similar experiment was conducted with the JM693 strain
that has the conditional secA1 in the secA2 mutant back-
ground (Fig. 6C). As expected because of the secA2mutation,
even in the absence of Atc this strain exhibited an export defect
for Msmeg1712-HA. The export defect seen when only SecA2
was absent was comparable with that observed when only
FIGURE 6. Expression of SecA1 and SecA2 is required for export of
Msmeg1712-HA. (A) Strain MSE10 (WT/conditional secA1), was either left
untreated or treated with 600 ng/ml Atc for 21 h to deplete SecA1. Cell wall
(CW), membrane (MEM), and SOL subcellular fractions were prepared from
whole cell lysate (WCL) of these cultures. For each fraction, protein derived
from an equal number of starting cells was analyzed by SDS-PAGE and immu-
noblot. The percentage of total Msmeg1712-HA localized to a given fraction
from Atc-treated MSE10 (B) or Atc-treated JM693 (C) (secA2/conditional
secA1) cultures was quantified using phosphorimaging and is reported as the
percentage of the total (cell wall plus membrane plus SOL). The results are the
mean of three independent experiments  standard error.*, p  0.05.
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SecA1 was depleted (Atc) in MSE10 (Fig. 6, B and C). When
SecA1 was depleted (Atc) in the secA2mutant background
of JM693, the defect in Msmeg1712-HA export was no greater
than that seenwhen only secA2was deleted/absent (Atc) (Fig.
6, B and C).
These results indicated that SecA1 and SecA2 are both
required for optimal export of Msmeg1712-HA. On their own,
neither SecA1 nor SecA2 are sufficient to export Msmeg1712-
HA. These data are the first to show that the canonical SecA1
has a role in exporting a substrate of the accessory SecA2
pathway.
DISCUSSION
The accessory SecA2 system of mycobacteria is a recent dis-
covery. In this study we showed that ATP binding is important
to the biological function of SecA2, we identified SecA2 as
being predominantly localized to the cytosol, and we demon-
strated a role for SecA1 in SecA2-dependent export. In addi-
tion, we showed that failure to express any SecA2 is better than
expressing a Walker Box mutant secA2 allele, and we showed
secA2 Walker Box mutants to be dosage-dependent dominant
negative alleles. These results provide valuable information for
understanding the mechanism of SecA2 export.
SecA2Must Bind ATP to Function in Vivo—Aprevious study
showed that SecA1 and SecA2 ofM. tuberculosis are functional
ATPases in vitro (25). Mutations in the Walker A (K108R) and
Walker B (D209N) motifs of E. coli SecA destroy ATP binding
and render SecA nonfunctional in a variety of in vitro and in
vivo assays (19, 40). InE. coli SecA, theseWalker Boxmutations
also alter the subcellular localization of SecA by preventing its
dissociation from the membrane as a consequence of failing to
cycle between ATP binding and hydrolysis. Here, we tested the
correspondingWalker Boxmutations inM. tuberculosis SecA2
(K115R) andM. smegmatis SecA2 (K129R).
InM. tuberculosis, we showed that the K115R substitution in
the Walker A motif of SecA2 was unable to complement a
smooth colony morphology phenotype of the M. tuberculosis
secA2mutant. Substitution of a Walker Box residue (D216N)
in theWalker Bmotif also renderedM. tuberculosis SecA2non-
functional (data not shown). SecA2 K115R is also unable to
carry out the SecA2 function of promoting M. tuberculosis
growth in macrophages (25). We believe that both the intracel-
lular growth defect and smooth colony morphology of the
secA2mutant are due to the inability of the secA2mutant to
export proteins that rely on the accessory SecA2 system. In
regard to the altered colony morphology of theM. tuberculosis
secA2 mutant, which we report here for the first time, we
speculate that it is due to defects in the bacterial cell surface
that arise from failure to export select cell wall biosynthetic
enzymes. Using M. smegmatis and SecA2 K129R, we directly
demonstrated the importance of SecA2 ATP binding to the
process of exporting Msmeg1704 and Msmeg1712.
Walker Box Mutant secA2 Alleles Are Dominant Negative—
The SecA2 Walker Box mutant alleles were not only nonfunc-
tional, as shown by the failure to complement, but in several
assays the Walker Box mutant alleles led to phenotypes worse
than that of a secA2 null mutant. Dominant negative muta-
tions often exhibit this type of behavior because many domi-
nant negative proteins still bind to their interacting proteins
and result in production of nonfunctional complexes (35–38).
When expressed in wild typeM. tuberculosis orM. smegmatis,
the Walker Box mutant secA2 alleles were, in fact, dominant
negative. Moreover, by using an inducible secA2 K129R allele
expressed inM. smegmatis, we showed that the severity of phe-
notypes associated with SecA2 K129R was dosage-dependent.
There is a precedent for substitutions in the Walker Box
lysine residue that we altered being dominant negative. As
mentioned above, the E. coli SecA K108R mutant was instru-
mental in demonstrating the importance of ATPase activity for
the canonical SecA (19). In an in vitro translocation assay, SecA
K108R inhibits proOmpA export in the presence of wild type
SecA. Although not specifically referred to as a dominant neg-
ative in this work, this result is consistent with SecA K108R
being dominant negative. The DotB ATPase that is part of the
Type IV secretion system of Legionella pneumophila and the
PilQ ATPase that is required for R64 pilus biogenesis are other
examples of ATPases that upon mutation of their Walker Box
motifs behave as dominant negatives (35, 36).
The Subcellular Localization of SecA1 and SecA2 Differs—
Previous studies in mycobacteria show that SecA1 and SecA2
are not functionally redundant; one SecA cannot compensate
for the other (4). In this work, we demonstrated a distinct dif-
ference between SecA1 and SecA2 in their subcellular localiza-
tion. SecA1 was equally distributed between cell envelope and
cytoplasmic fractions ofM. smegmatis, as is the case for E. coli
SecA. In contrast, SecA2 was found predominantly in the cyto-
plasmic fraction. Fractions prepared from M. tuberculosis
whole cell lysates showed a similar difference in subcellular
localization of SecA1 and SecA2 (data not shown). This result is
significant in suggesting that the roles played by SecA1 and
SecA2 in protein export differ. Interestingly, the localization of
the two SecA homologs of S. parasanguinis also differs (41). In
S. parasanguinis, the canonical SecA is again found equally dis-
tributed in cell envelope and soluble fractions. However, oppo-
site to our finding, in S. parasanguinis SecA2 is predominantly
associated with the cell envelope.
A Model to Explain SecA2 Function and the Phenotypes of
Walker Box Mutant secA2 Alleles—From the results of our
study, we developed a model for SecA2 function in mycobacte-
ria (Fig. 7). In a wild type cell, we propose that SecA2 predom-
inantly resides in the cytosol, but it interacts in a transient fash-
ionwith amembrane-embedded translocase to promote export
of a select subset of proteins. The Walker Box mutation
(K129R) renders SecA2 catalytically “dead.” However, this dead
protein appears able to still interact with its binding partners
but because of the inability to hydrolyze ATP remains locked in
a complex. In this way, the dead SecA2 protein could remain at
the membrane titrating up interacting proteins, which is con-
sistent with the altered subcellular distribution of SecA2
K129R. If the titrated SecA2-interacting proteins have addi-
tional functions in the cell, this would lead to phenotypes more
severe than those exhibited by a secA2 null mutation. In fact,
this is what we observed.With this model in mind, as the levels
of SecA2 K129R increase we would also expect the observed
phenotypes to become more severe. Because of the growth
inhibitory phenotypes observed upon high level expression of
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SecA2 K129R, we believe the proteins tied up by SecA2 K129R
are important to an essential process. Unlike the accessory
SecA2/Y2 systems of S. gordonii and S. parasanguinis, the
accessory SecA2 system in mycobacteria lacks an accessory
SecY homolog or obvious translocase (6, 27, 42). Consequently,
the essential SecA1/SecYEG translocase is an attractive candi-
date for being the interacting protein complex tied up by SecA2
K129R and for being the translocase used by SecA2.However, it
is also possible that SecA2 interacts with an unidentified mem-
brane-embedded translocase to export precursors out of the
cytoplasm.
If SecA2 uses the canonical SecA1/SecYEG translocase to
export its subset of proteins, then proteins that depend on
SecA2 for export should also depend on SecA1/SecYEG. Here
we showed that when SecA1was depleted in wild typeM. smeg-
matis, Msmeg1712 was not efficiently exported to the cell wall.
The export defect observed upon SecA1 depletion was compa-
rable with that exhibited by a secA2 mutant. This result
reveals a role for the essential SecA1 in the SecA2-dependent
process of exporting Msmeg1712.
Although we showed a requirement for SecA1 in mycobac-
terial SecA2 export, the precise nature of the role of SecA1 is
not yet clear. One possibility is that SecA1 and SecA2 directly
interact to form a heterodimer capable of exporting a subset of
proteins, like Msmeg1712, through the SecYEG translocase. In
E. coli, SecA forms dimers, although the exact role of dimers in
protein translocation remains in dispute (43–45). However, as
of now, there is no evidence of a physical interaction between
SecA1 and SecA2. An alternative is that the role of SecA2 is to
recognize precursor substrates in the cytoplasm that are nor-
mally overlooked by SecA1. Upon recognition, SecA2may then
deliver these precursor proteins to the SecA1/SecYEG translo-
case complex for export. This type of function for SecA2 would
be compatible with its primarily cytosolic location. Another
possibility is that SecA2 works with SecA1 to promote export
via a novel translocase.
A final possibility, which we consider less likely, is that the
contribution of SecA1 is to assemble integral membrane pro-
teins into a novel translocase for SecA2-dependent proteins. It
appears that E. coli SecA can participate in assembling certain
domains of some multi-spanning integral membrane proteins
(46). However, the signal recognition particle GTPase, not
SecA, is the requisite factor required for integral membrane
insertion, and a role for SecA may be rare because there are
integral membrane proteins clearly shown to not require SecA
(47, 48). Furthermore, there is no evidence that SecA1 func-
tions in assembling cytoplasmic membrane proteins of
mycobacteria.
Our results from studying the Walker Box mutants are con-
sistent in bothM. tuberculosis andM. smegmatis, and we dem-
onstrated the ability of each SecA2 to function in cross-species
complementation experiments. However, there currently re-
mains a discrepancy in the types of exported proteins iden-
tified as dependent on SecA2 for export in each of these
mycobacteria. So far, SecA2-dependent proteins identified
for M. tuberculosis lack obvious signal sequences (SodA)
(5), whereas the two known SecA2-dependent proteins
(Msmeg1704 and Msmeg1712) ofM. smegmatis contain sig-
nal sequences (24). We believe this difference reflects our
limited appreciation of the proteins exported by the SecA2
export system in each species. For this reason, we are con-
tinuing our search for additional SecA2-dependent proteins.
Clearly, identifying proteins that interact with SecA2 will be
important for fully understanding the relationship between the
essential SecA1/SecYEG pathway and the accessory SecA2
pathway. Dominant negative alleles, often in combination with
suppressor mutations, can be extremely useful in identifying
proteins that work together in a biological pathway. During the
course of the work described here, we isolated spontaneous
suppressors of the dominant negative secA2 K129R allele inM.
smegmatis. Going forward, we believe these suppressors will be
useful in identifying proteins that work with SecA2 in protein
export. It is our hope that a thorough understanding of the
accessory SecA2 system will aid the identification of new tar-
gets for anti-mycobacterial therapies.
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